NPS Pharmaceuticals (NPSP) is a clinical-stage biopharmaceutical company. NPS Pharma is focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and high unmet medical needs. This stock is trading up 7% at $7.26 in recent trading.
Today's Range: $6.77-$7.2752-Week Range: $4.35-$10.33 Volume: 755,000 Three-Month Average Volume: 672,986 >>5 Stocks Under $10 Poised for Breakouts From a technical perspective, NPSP is soaring here back above its 50-day moving average of $7.18 with above average volume. This move is now setting NPSP up for a much larger trend higher. Traders should continue to look for long-biased trades as long as NPSP is trending above its 50-day with strong upside volume flows. I would consider any upside volume day that registers near or above 672,986 shares as bullish. If we continue to see that trend, then look for NPSP to re-test $7.60 and then possibly fill a previous gap back towards $8 to $8.35. This stock has some major overhead resistance at $8.35 to $8.48, so if it were to take those levels out with volume it would be very bullish in the near-term. On the flipside, I would avoid this stock or look for short-biased trades if it fails to get into that gap, or if it drops back below its 50-day with heavy volume.